About Anushka Dutta

With a master's degree in economics, she aims to help investors identify untapped investment opportunities by looking at the fundamental factors.


Recent Articles By Anushka Dutta

: VRTX |  News, Ratings, and Charts

3 Biotech Stocks to Invest In Right Now for Long-Term Gains

With the rapidly growing demand for personalized medicine, innovative solutions, and recent developments like AI in drug discovery, the biotech industry's prospects appear robust. Thus, quality biotech stocks Vertex Pharmaceuticals (VRTX), SIGA Technologies (SIGA), and Gilead Sciences (GILD) could be ideal candidates to buy now. Read more…
: OXY |  News, Ratings, and Charts

OXY Earnings Spotlight: Actionable Insights and Gameplan

With expectations of an oil supply shortage and a multi-billion-dollar acquisition on the cards, does energy giant Occidental Petroleum (OXY) deserve a place in your portfolio prior to its fourth-quarter earnings release? Let’s look at its financial metrics to know more…
: WMB |  News, Ratings, and Charts

Williams Companies (WMB) Earnings Watch: Strategies for Energy Investors

After announcing a raised dividend and a significant acquisition, energy company The Williams Companies (WMB) is set to unveil its fourth-quarter earnings tomorrow. Is the stock a buy for energy investors now? Let’s look at its financial metrics to gauge its prospects…
: ABNB |  News, Ratings, and Charts

ABNB: Buy or Watch Ahead of Earnings?

After posting strong topline and bottom-line growth in the third quarter, does Airbnb, Inc. (ABNB) deserve a place in your portfolio ahead of its fourth-quarter earnings release tomorrow? Let’s look at its financial metrics to know more…
: DIS |  News, Ratings, and Charts

Disney (DIS) Earnings Alert: Key Insights for Investors

Media giant The Walt Disney Company (DIS) is set to report its fiscal first-quarter results tomorrow amid turmoil regarding potential board changes. Should you invest in the stock now? Let’s look at its financial metrics to gauge its prospects…
: NXPI |  News, Ratings, and Charts

NXPI Earnings Preview: Decoding Buy Signals

Should investors consider investing in NXP Semiconductors N.V. (NXPI) before its fourth-quarter earnings release amid a rebounding chip market? Let’s look at its financial metrics to know more…
: QCOM |  News, Ratings, and Charts

QUALCOMM (QCOM): Decoding Earnings for Buy Signals

Chipmaker QUALCOMM (QCOM) reported an earnings beat amid a recovering semiconductor market. Let’s look at its financial metrics to gauge whether the stock is exhibiting buy signals. Read on…
: ABBV |  News, Ratings, and Charts

Pharma Watchlist: 3 Stocks Worth Adding

The pharma industry embraces digital trends and advancements in clinical research in 2024, with prospects of significant expansion. Hence, fundamentally strong pharma stocks Dr. Reddy's Laboratories (RDY), Amneal Pharmaceuticals (AMRX), and AbbVie (ABBV) might be worth adding to one’s watchlist. Read more…
: META |  News, Ratings, and Charts

Meta (META): Analyzing Buy Signals Pre-Earnings Release

With possible regulatory action and a “year of efficiency,” should investors consider investing in Meta Platforms (META) prior to its fourth-quarter earnings release tomorrow? Let’s look at its financial metrics to gauge its prospects…
: V |  News, Ratings, and Charts

Visa Inc. (V) Earnings Spotlight: What to Watch for in the Report

Consumer spending is holding up, which might bode well for Visa Inc. (V). Amid expanding operations, is the stock a buy before its first-quarter results tomorrow? Let’s look at its financial metrics to gauge its prospects…
Page generated in 1.0926 seconds.